GENEOS Therapeutics, Inc. — Form D
GENEOS Therapeutics, Inc. of PLYMOUTH MEETING, PA, a company, filed a Form D exempt-offering notice with the SEC on 2019-02-27. The offering totals $10.5M, of which $4.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-02-27
- Form: D
- Accession: 0001769177-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.5M
- Amount sold: $4.5M
- Remaining: $6.0M
- Investors: 3
- Date of first sale: 2019-02-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-333669
Issuer
- Name: GENEOS Therapeutics, Inc.
- CIK: 0001769177
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 660 WEST GERMANTOWN PIKE, PLYMOUTH MEETING, PA, 19462
- Phone: (267) 440-4232
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| Samuel Y Dr. Broder | Director | Plymouth Meeting, PA |
| Casey Cunningham | Director | Milwaukee, WI |
| Ted Fjallman | Director | Philadelphia, PA |
| Laurent Y Humeau | Director | Plymouth Meeting, PA |
| James Y Eadie | Director | Plymouth Meeting, PA |
| Niranjan Y Sardesai | Director | Plymouth Meeting, PA |
| Niranjan Y Sardesai | Executive Officer | Plymouth Meeting, PA |
| Samuel Y Broder | Director | Plymouth Meeting, PA |
| Sangwoo Y Lee | Director | Plymouth Meeting, PA |
| Casey Y Cunningham | Director | Plymouth Meeting, PA |
| Ted Y Fjallman | Director | Plymouth Meeting, PA |
| Joseph Kim | Director | London, X0 |
| Samuel Broder | Director | Plymouth Meeting, PA |
| Sangwoo Lee | Director | Plymouth Meeting, PA |
| Niranjan Sardesai | Director | Plymouth Meeting, PA |
| Niranjan Sardesai | Executive Officer | Plymouth Meeting, PA |
| Eadie James | Director | Plymouth Meeting, PA |
| J. Joseph Kim | Director | Plymouth Meeting, PA |
| Casey Joseph Cunningham | Director | Plymouth Meeting, PA |
| Samuel Joseph Broder | Director | Plymouth Meeting, PA |
| Sangwoo Joseph Lee | Director | Plymouth Meeting, PA |
Other filings by this issuer (3)
More